Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention

NCT06409299 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Tracheomalacia
Bronchopulmonary Dysplasia (BPD)
Vascular Ring
Cystic Lung Disease
Bronchiectasis
Chronic Atelectasis

Interventions

DRUG: Azithromycin 40 MG/ML
OTHER: Placebo

Sponsor

Rigshospitalet, Denmark